Teratogenic effects of thalidomide: molecular mechanisms.
Ito T, Ando H, Handa H.
Cell Mol Life Sci · research support, non-u.s. gov't; review-article; review; journal article · DOI 10.1007/s00018-010-0619-9 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för thalidomide. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
9 träffarRole of thalidomide in previously untreated patients with multiple myeloma.
Musto P, D'Auria F, Pietrantuono G, Bringhen S, Morabito F, Di Raimondo F, Pozzi S, Sacchi S, Boccadoro M, Palumbo A, Gruppo Italiano Malatte Ematologiche dell'Adulto Multiple Myeloma Working Party, Italian Myeloma Network and Gruppo Italiano Studio Linfomi.
Expert Rev Anticancer Ther · review; journal article · DOI 10.1586/14737140.8.10.1569Thalidomide inhibits pentylenetetrazole-induced seizures.
Palencia G, Calderon A, Sotelo J.
J Neurol Sci · research support, non-u.s. gov't; journal article · DOI 10.1016/j.jns.2007.03.010[Desirable and undesirable effects of thalidomide in patients with multiple myeloma].
Foldyna D, Kamelander J, Krejcí M, Hájek R.
Vnitr Lek · journal article; english abstract[Thalidomide: new perspectives for its use as antiinflammatory, immunossupressive and antiangiogenic drug].
Borges Lde G, Frõehlich PE.
Rev Assoc Med Bras (1992) · review; journal article; english abstract · DOI 10.1590/s0104-42302003000100041Efficacy of thalidomide therapy for extramedullary relapse of myeloma following allogeneic transplantation.
Biagi JJ, Mileshkin L, Grigg AP, Westerman DW, Prince HM.
Bone Marrow Transplant · journal article; case reports · DOI 10.1038/sj.bmt.1703292Thalidomide as an anti-angiogenic agent in relapsed gliomas.
Short SC, Traish D, Dowe A, Hines F, Gore M, Brada M.
J Neurooncol · clinical trial, phase ii; clinical trial; research support, non-u.s. gov't; journal article · DOI 10.1023/a:1006414804835[Typical migraine and thalidomide].
García-Albea E, Cabrera F, Tejeiro J, Jiménez-Jiménez FJ.
Med Clin (Barc) · letter; case reports[Thalidomide: an eclectic medication in dermatology].
Proença NG.
Rev Paul Med · review; journal article; english abstract